https://scholars.lib.ntu.edu.tw/handle/123456789/496613
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Shui H.-A. | en_US |
dc.contributor.author | Hsia C.-W. | en_US |
dc.contributor.author | Chen H.-M. | en_US |
dc.contributor.author | TIEN-CHUN CHANG | en_US |
dc.contributor.author | CHIH-YUAN WANG | en_US |
dc.creator | Wang C.-Y.;TIEN-CHUN CHANG;Chen H.-M.;Hsia C.-W.;Shui H.-A. | - |
dc.date.accessioned | 2020-06-03T07:23:46Z | - |
dc.date.available | 2020-06-03T07:23:46Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 1874-3919 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855905371&doi=10.1016%2fj.jprot.2011.10.029&partnerID=40&md5=2e270a4f7b6d7da29190402c457024ca | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/496613 | - |
dc.description.abstract | Lovastatin (lova), a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, can induce differentiation in cancer cells at low concentration, thus having potential to be used as an auxiliary agent in cancer therapy. However, biological networks associated with the differentiation effect of lova have not been elucidated. To investigate molecular mechanisms of lova, the present study was aimed at proteomics and bioinformatics analyses on anaplastic thyroid cancer cell line ARO differentiated with low concentration of lova. Thyroid differentiation was induced by treating ARO cells with 25 μM of lova and confirmed by checking upregulation of some thyroid differentiation markers. Gel-based proteomics analysis was then performed to identify proteins differentially expressed between undifferentiated and lova-differentiated ARO cells. Bioinformatics analysis was finally performed to estimate biological networks regulated by lova. Our results showed that lova impacted on proteins involved in protein folding, biomolecule metabolism, signal transduction, protein expression and protein degradation. Specifically, transfecting ARO cells with plasmid DNA encoding flotillin 1 (FLOT1) up-regulated the thyroid differentiation markers, indicating that FLOT1 might at least partially mediate the lova-induced thyroid differentiation. These data may shed light on the mechanism underlying lova-induced re-differentiation of thyroid cancer, and give a rationale for clinical use of lova as an auxiliary agent in cancer therapy. ? 2011 Elsevier B.V. | en_US |
dc.relation.ispartof | Journal of Proteomics | en_US |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | flotillin 1; mevinolin; anaplastic carcinoma; article; cancer cell; cell differentiation; drug mechanism; enzyme induction; genetic transfection; human; human cell; nucleotide sequence; priority journal; protein analysis; protein degradation; protein expression; protein folding; signal transduction; structural bioinformatics; structural proteomics; Blotting, Western; Cloning, Molecular; Computational Biology; DNA Fragmentation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Membrane Proteins; Protein Folding; Proteomics; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thyroid Neoplasms | - |
dc.title | Proteomics and bioinformatics analysis of lovastatin-induced differentiation in ARO cells | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.jprot.2011.10.029 | - |
dc.identifier.pmid | 22086082 | - |
dc.identifier.scopus | 2-s2.0-84855905371 | - |
dc.relation.pages | 1170-1180 | en_US |
dc.relation.journalvolume | 75 | en_US |
dc.relation.journalissue | 4 | en_US |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Medicine-NTUCC | - |
crisitem.author.orcid | 0000-0003-3385-2026 | - |
crisitem.author.orcid | 0000-0002-6742-3935 | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。